PHARMA
WuXi STA Opens Nucleic Acid Drug Manufacturing Facility
Nucleic acid drugs have the potential to treat neuromuscular and metabolic diseases where small molecule drugs have failed.
Boehringer Ingelheim And Enleofen Bio Strike Billion-Dollar Deal
Enleofen Bio will receive more than US$1 billion in earnout payments from Boehringer Ingelheim’s acquisition of worldwide exclusive rights to its preclinical interleukin-11 platform.
Astrazeneca Launches Three R&D Initiatives In China
With the creation of two new research centres and a billion-dollar fund in China, AstraZeneca looks set to make waves in biomedical research and healthcare in Asia.
WuXi AppTec And BioSolveIT Set Up Molecule Library
The GalaXi® platform grants researchers access to billions of virtual molecules, paving the way for faster drug discovery and development.
China Approves Keytruda For Lung Cancer Treatment
Merck’s Keytruda is the first anti-PD-1 therapy to be approved as monotherapy, and in combination with chemotherapy, for lung cancer patients in China.
ASLAN And Bukwang Team Up To Develop Immune-Oncology Drugs
The joint venture has resulted in the independent company JAGUAHR Therapeutics, which will focus on developing aryl hydrocarbon receptor antagonists for cancer treatment.
AstraZeneca’s Lung Cancer Drug Receives Regulatory Approval In China
Tagrisso, a small molecule inhibitor drug, has been approved in China as a first-line treatment for patients with non-small cell lung tumors bearing specific mutations.
GSK Opens US$96M Facility In Singapore
Following a S$130-million investment, GSK has launched a new pharmaceutical manufacturing facility in Singapore.
CAR-T Therapy Shows Promising Results Against Myeloma
Innovent Biologics' CT103A, a promising therapy for tough-to-treat blood cancer, has shown positive results in clinical trials.
